Skip to main content
Top
Published in: Medical Microbiology and Immunology 3/2008

01-09-2008 | Original Investigation

Varicella-zoster virus infection induces the secretion of interleukin-8

Authors: Nathalie Desloges, Christiane Schubert, Manfred H. Wolff, Markus Rahaus

Published in: Medical Microbiology and Immunology | Issue 3/2008

Login to get access

Abstract

Interleukin-8 (IL-8) is an important mediator in neutrophil-mediated acute inflammation but has also a wide range of actions on various cells types. We demonstrated that infection of melanoma cells and fibroblasts with cell-associated varicella-zoster virus (VZV) and infection of a T cell line with cell-free VZV resulted in an induction of IL-8 secretion in vitro. The inhibition of the VZV replication with a drug interfering with its DNA replication had no effect on the IL-8 release. Since the IL-8 promoter contains binding sites for NF-κB and AP-1, melanoma cells and the T cell line were treated with inhibitors of NF-κB, JNK/SAPK or p38/MAPK prior to infection. In melanoma cells, the JNK/SAPK pathway was shown to be important for the IL-8 secretion during the VZV replication, whereas in the T cell line, not only the JNK/SAPK but also the p38/MAPK pathways were required for IL-8 secretion. The neutralisation of the IL-8 bioactivity had no significant consequence on the VZV replication, suggesting that IL-8 acts neither as a proviral nor as an antiviral cytokine during the VZV replication in vitro.
Literature
1.
2.
go back to reference Desloges N, Rahaus M, Wolff MH (2005) The varicella-zoster virus-mediated delayed host shutoff: open reading frame 17 has no major function, whereas immediate-early 63 protein represses heterologous gene expression. Microbes Infect 7:1519–1529PubMedCrossRef Desloges N, Rahaus M, Wolff MH (2005) The varicella-zoster virus-mediated delayed host shutoff: open reading frame 17 has no major function, whereas immediate-early 63 protein represses heterologous gene expression. Microbes Infect 7:1519–1529PubMedCrossRef
4.
go back to reference Di Valentin E, Bontemps S, Habran L, Jolois O, Markine-Goriaynoff N, Vanderplasschen A, Sadzot-Delvaux C, Piette J (2005) Varicella-zoster virus IE63 protein represses the basal transcription machinery by disorganizing the pre-initiation complex. Biol Chem 386:255–267PubMedCrossRef Di Valentin E, Bontemps S, Habran L, Jolois O, Markine-Goriaynoff N, Vanderplasschen A, Sadzot-Delvaux C, Piette J (2005) Varicella-zoster virus IE63 protein represses the basal transcription machinery by disorganizing the pre-initiation complex. Biol Chem 386:255–267PubMedCrossRef
5.
go back to reference Jones JO, Arvin AM (2006) Inhibition of the NF-κB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J Virol 80:5113–5124PubMedCrossRef Jones JO, Arvin AM (2006) Inhibition of the NF-κB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J Virol 80:5113–5124PubMedCrossRef
6.
go back to reference Kadoya H, Nagano-Fujii M, Deng L, Nakazono N, Hotta H (2005) Nonstructural proteins 4A and 4B of hepatitis C virus transactivate the interleukin 8 promoter. Microbiol Immunol 49:265–2739PubMed Kadoya H, Nagano-Fujii M, Deng L, Nakazono N, Hotta H (2005) Nonstructural proteins 4A and 4B of hepatitis C virus transactivate the interleukin 8 promoter. Microbiol Immunol 49:265–2739PubMed
7.
go back to reference Khabar KS, Al-Zoghaibi F, Al-Ahdal MN, Murayama T, Dhalla M, Mukaida N, Taha M, Al-Sedairy ST, Siddiqui Y, Kessie G, Matsushima K (1997) The α chemokine, interleukin 8, inhibits the antiviral action of interferon α. J Exp Med 186:1077–1085PubMedCrossRef Khabar KS, Al-Zoghaibi F, Al-Ahdal MN, Murayama T, Dhalla M, Mukaida N, Taha M, Al-Sedairy ST, Siddiqui Y, Kessie G, Matsushima K (1997) The α chemokine, interleukin 8, inhibits the antiviral action of interferon α. J Exp Med 186:1077–1085PubMedCrossRef
8.
go back to reference Khabar KSA, Al-Zoghaibi F, Murayama T, Matsushima K, Mukaida N, Siddiqui Y, Dhalla M, Al-Ahdal MN (1997) Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line. Biochem Biophys Res Commun 235:774–778PubMedCrossRef Khabar KSA, Al-Zoghaibi F, Murayama T, Matsushima K, Mukaida N, Siddiqui Y, Dhalla M, Al-Ahdal MN (1997) Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line. Biochem Biophys Res Commun 235:774–778PubMedCrossRef
9.
go back to reference Ku C-C, Besser J, Abendroth A, Grose C, Arvin AM (2005) Varicella-zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol 79:2651–2658PubMedCrossRef Ku C-C, Besser J, Abendroth A, Grose C, Arvin AM (2005) Varicella-zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol 79:2651–2658PubMedCrossRef
10.
go back to reference Ku C-C, Padilla JA, Grose C, Butcher EC, Arvin AM (2002) Tropism of varicella-zoster virus for human tonsillar CD4+ T lymphocytes that express activation, memory, and skin homing markers. J Virol 76:11425–11433PubMedCrossRef Ku C-C, Padilla JA, Grose C, Butcher EC, Arvin AM (2002) Tropism of varicella-zoster virus for human tonsillar CD4+ T lymphocytes that express activation, memory, and skin homing markers. J Virol 76:11425–11433PubMedCrossRef
11.
go back to reference Mahe Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S (1991) Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem 266:13759–13763PubMed Mahe Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S (1991) Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem 266:13759–13763PubMed
12.
go back to reference Malmgaard L (2004) Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 24:439–454PubMedCrossRef Malmgaard L (2004) Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 24:439–454PubMedCrossRef
13.
go back to reference Mastronarde JG, Monick MM, Mukaida N, Matsushima K, Hunninghake GW (1998) Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-κB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis 177:1275–1281PubMedCrossRef Mastronarde JG, Monick MM, Mukaida N, Matsushima K, Hunninghake GW (1998) Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-κB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis 177:1275–1281PubMedCrossRef
14.
go back to reference Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Appella E, Kung HF, Leonard EJ, Oppenheim JJ (1988) Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 167:1883–1893PubMedCrossRef Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Appella E, Kung HF, Leonard EJ, Oppenheim JJ (1988) Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 167:1883–1893PubMedCrossRef
15.
go back to reference Mori N, Mukaida N, Ballard DW, Matsushima K, Yamamoto N (1998) Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-κB-like sites. Cancer Res 58:3993–4000PubMed Mori N, Mukaida N, Ballard DW, Matsushima K, Yamamoto N (1998) Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-κB-like sites. Cancer Res 58:3993–4000PubMed
16.
go back to reference Mukaida N (2000) Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72:391–398PubMed Mukaida N (2000) Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72:391–398PubMed
17.
go back to reference Mukaida N (2003) Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 284:L566–L577PubMed Mukaida N (2003) Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 284:L566–L577PubMed
18.
go back to reference Murayama T, Kuno K, Jisaki F, Obuchi M, Sakamuro D, Furukawa T, Mukaida N, Matsushima K (1994) Enhancement of human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. J Virol 68:7582–7585PubMed Murayama T, Kuno K, Jisaki F, Obuchi M, Sakamuro D, Furukawa T, Mukaida N, Matsushima K (1994) Enhancement of human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. J Virol 68:7582–7585PubMed
19.
go back to reference Murayama T, Ohara Y, Obuchi M, Khabar KS, Higashi H, Mukaida N, Matsushima K (1997) Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1 and NF-κB-binding sites of the interleukin-8 gene. J Virol 71:5692–5695PubMed Murayama T, Ohara Y, Obuchi M, Khabar KS, Higashi H, Mukaida N, Matsushima K (1997) Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1 and NF-κB-binding sites of the interleukin-8 gene. J Virol 71:5692–5695PubMed
20.
go back to reference Polyak SJ, Khabar KS, Paschal DM, Ezelle HJ, Duverlie G, Barber GN, Levy DE, Mukaida N, Gretch DR (2001) Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 75:6095–6106PubMedCrossRef Polyak SJ, Khabar KS, Paschal DM, Ezelle HJ, Duverlie G, Barber GN, Levy DE, Mukaida N, Gretch DR (2001) Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 75:6095–6106PubMedCrossRef
21.
go back to reference Rahaus M, Desloges N, Wolff MH (2004) Replication of varicella-zoster virus is influenced by the levels of JNK/SAPK and p38/MAPK activation. J Gen Virol 85:3529–3540PubMedCrossRef Rahaus M, Desloges N, Wolff MH (2004) Replication of varicella-zoster virus is influenced by the levels of JNK/SAPK and p38/MAPK activation. J Gen Virol 85:3529–3540PubMedCrossRef
22.
go back to reference Rahaus M, Wolff MH (2003) Reciprocal effects of varicella-zoster virus (VZV) and AP1: activation of jun, fos and ATF-2 after VZV infection and their importance for the regulation of viral genes. Virus Res 92:9–21PubMedCrossRef Rahaus M, Wolff MH (2003) Reciprocal effects of varicella-zoster virus (VZV) and AP1: activation of jun, fos and ATF-2 after VZV infection and their importance for the regulation of viral genes. Virus Res 92:9–21PubMedCrossRef
23.
go back to reference Roebuck KA (1999) Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 19:429–438PubMedCrossRef Roebuck KA (1999) Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 19:429–438PubMedCrossRef
24.
go back to reference Sadzot-Delvaux C, Rentier B (2000) Animal models of infection. In: Arvin AM, Gershon AA (eds) Varicella-zoster virus—virology and clinical management. Cambridge University Press, UK, pp 169–184 Sadzot-Delvaux C, Rentier B (2000) Animal models of infection. In: Arvin AM, Gershon AA (eds) Varicella-zoster virus—virology and clinical management. Cambridge University Press, UK, pp 169–184
25.
go back to reference Soong W, Schultz JC, Patera AC, Sommer MH, Cohen JI (2000) Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J Virol 74:1864–1870PubMedCrossRef Soong W, Schultz JC, Patera AC, Sommer MH, Cohen JI (2000) Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J Virol 74:1864–1870PubMedCrossRef
26.
go back to reference Strieter RM (2002) Interleulin-8: a very important chemokine of the human airway epithelium. Am J Physiol Lung Cell Mol Physiol 283:L688–L689PubMed Strieter RM (2002) Interleulin-8: a very important chemokine of the human airway epithelium. Am J Physiol Lung Cell Mol Physiol 283:L688–L689PubMed
27.
go back to reference Torigo S, Ihara T, Kamiya H (2000) IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella. Microbiol Immunol 44:1027–1031PubMed Torigo S, Ihara T, Kamiya H (2000) IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella. Microbiol Immunol 44:1027–1031PubMed
28.
go back to reference Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW (2005) Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol 79:12658–12666PubMedCrossRef Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW (2005) Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol 79:12658–12666PubMedCrossRef
29.
go back to reference Zak-Prelich M, McKenzie RC, Sysa-Jedrzejowska A, Norval M (2003) Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia. Clin Exp Immunol 131:318–323PubMedCrossRef Zak-Prelich M, McKenzie RC, Sysa-Jedrzejowska A, Norval M (2003) Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia. Clin Exp Immunol 131:318–323PubMedCrossRef
Metadata
Title
Varicella-zoster virus infection induces the secretion of interleukin-8
Authors
Nathalie Desloges
Christiane Schubert
Manfred H. Wolff
Markus Rahaus
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 3/2008
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-007-0060-3

Other articles of this Issue 3/2008

Medical Microbiology and Immunology 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.